IVD 檢測開發市場規模、佔有率、預測、趨勢分析：按產品（檢測開發、包裝開發）、按技術（免疫檢測、分子診斷、生物化學）、按應用（腫瘤學、糖尿病）- 到 2031 年世界預測

預計到 2031 年，全球 IVD 檢測開發市場將達到 83.9 億美元，2024 年至 2031 年複合年增長率為 7.9%。

本報告在廣泛的二級和一級研究以及對市場情景的深入分析後，對關鍵行業推動因素、阻礙因素、挑戰和機會進行了分析。該市場的成長是由慢性病患病率上升和老年人口增加、傳染病負擔高、對POC IVD檢測市場開發的日益關注以及醫療保健支出的增加所推動的。然而，不斷變化的監管環境正在限制市場成長。

此外，新興經濟體和 IVD 檢測開發中先進技術的利用預計將為該市場的參與者提供成長機會。然而，維持產品品質和保護專有資訊是影響市場成長的主要挑戰。

本報告基於對主要公司的產品和區域格局以及過去幾年（2021-2024 年）採取的主要成長策略的廣泛評估，提供了競爭格局。全球 IVD 檢測開發市場的主要公司包括 Thermo Fisher Scientific Inc.（美國）、Avioq, Inc.（美國）、Creative Biolabs, Inc.（美國）、Maxim Biomedical, Inc.（美國）、Bio-Techne Corporation （美國）、Merck KGaA（德國）、PeploBio Ltd（英國）、ICON plc（愛爾蘭）、NeoDx Biotech Labs Pvt. Ltd.（印度）、Eclevar Medtech（法國）、Savyon Diagnostics（以色列）、Promega Corporation（美國）和 Future Diagnostics Solutions B.V.（荷蘭）。

在本報告涵蓋的產品中，IVD 穩定性測試領域預計在 2024 年至 2031 年的預測期內複合年增長率最高，將超過 8.1%。推動這種成長的是穩定性測試的好處，它有助於識別潛在的故障和效能隨時間的變化。穩定性測試使公司能夠檢測和管理與影響體外診斷有效性的因素相關的風險，例如光照和溫度變化。

在本報告涵蓋的技術中，免疫分析/免疫化學領域預計將在 2024 年佔據 IVD 分析開發市場的最大佔有率。該行業的高市場佔有率是由於免疫診斷因其固有的特定性和高通量而比其他技術更受青睞，以及先進的診斷免疫分析形式的出現。

在本報告涵蓋的應用中，傳染病領域預計將在 2024 年佔據 IVD 檢測開發市場的最大佔有率。該細分市場的巨大市場佔有率歸因於愛滋病毒流行率的不斷上升以及愛滋病毒快速診斷檢測的日益普及。

對全球 IVD 檢測開發市場區域狀況的詳細分析，提供了五個主要地區（北美、歐洲、亞太地區、拉丁美洲、中東和非洲）的詳細定性和定量見解，涵蓋了主要國家。到 2024 年，北美預計將佔據 IVD 檢測開發市場的最大佔有率，超過 37.8%。在該地區，美國預計到 2024 年將佔據 IVD 檢測開發市場的最大佔有率。該國的高市場佔有率歸因於傳染病流行的蔓延、政府對疾病監測和預防的穩定投資和融資以及醫療保健支出的增加。

調查範圍：

IVD 檢測開發市場：依產品分類

• IVD 檢測開發服務
• IVD 包裝開發服務
• IVD檢測穩定性測試
• 監理支持
• 其他產品

（註：其他服務包括技術轉移、技術支援服務以及客製化 QA 和 QC 測試）

IVD 檢測開發市場：依技術劃分

• 免疫測定/免疫化學
• 分子診斷
• 臨床化學/生物化學
• 血液學
• 微生物學
• 尿液測試

IVD 檢測開發市場：依應用劃分

• 傳染病
• 腫瘤學
• 糖尿病
• 循環系統
• 其他用途

（註：其他用途包括腎臟科、凝血測試、神經系統疾病）

按地區劃分的 IVD 檢測開發市場

• 北美
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳大利亞
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地區
• 中東/非洲

目錄

第一章簡介

第二章研究方法

第 3 章執行摘要

第 4 章市場洞察

• 市場概覽
• 影響市場成長的因素
  • 促進因素
    • 慢性病盛行率上升和老年人口增加
    • 傳染病負擔高
    • 越來越關注 POC IVD 檢測開發
    • 醫療支出增加
  • 阻礙因素
    • 監理情況的變化
  • 機會
    • 新興經濟體
    • 在 IVD 檢測開發中使用先進技術
  • 課題
    • 維護產品品質並保護專有訊息
  • 宏觀指標
• 鄰近市場分析
• IVD 檢測開發市場：監管狀況
  • 北美
    • 美國
    • 加拿大
  • 歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
  • 拉丁美洲
  • 中東/非洲
• 波特五力分析

第 5 章 IVD 檢測開發市場評估：依產品

• 摘要
• IVD 檢測開發服務
• IVD檢測穩定性測試
• IVD 包裝開發服務
• 監理支持
• 其他服務

第 6 章 IVD 檢測開發市場：按技術

• 摘要
• 免疫測定/免疫化學
• 分子診斷
• 臨床化學/生物化學
• 血液學
• 微生物學
• 尿液測試

第 7 章 IVD 檢測開發市場評估：按應用

• 摘要
• 傳染病
• 腫瘤學
• 糖尿病
• 循環系統
• 其他用途

第 8 章 IVD 檢測開發市場評估：按地區

• 摘要
• 北美
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳大利亞
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地區
• 中東/非洲

第9章競爭分析

• 摘要
• 競爭基準測試
• 競爭對手儀表板
  • 行業領導者
  • 市場差異化因素
  • 先鋒
  • 新興公司
• 市場排名：以主要公司劃分（2023 年）

第 10 章公司簡介（業務概覽、財務概覽、產品組合、策略發展、SWOT 分析*）

• Creative Biolabs, Inc.
• Avioq, Inc.
• Thermo Fisher Scientific Inc.
• Neodx Biotech Labs Pvt. Ltd.
• Merck KGaA
• PeploBio Ltd
• Icon Plc
• Savyon Diagnostics
• Maxim Biomedical, Inc.
• Eclevar Medtech
• Promega Corporation
• Future Diagnostics Solutions B.V.

（註：提供前 5 名公司的 SWOT 分析）

第11章附錄

The global IVD assay development market is projected to reach $8.39 billion by 2031 at a CAGR of 7.9% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of this market is driven by the rising prevalence of chronic diseases & the increasing geriatric population, the high burden of infectious diseases, the growing focus on the development of POC IVD assays, and rising healthcare expenditures. However, the evolving regulatory landscape restrains the growth of this market.

Furthermore, the emerging economies and the use of advanced technologies in IVD assay development are expected to generate growth opportunities for the players operating in this market. However, maintaining product quality & protecting proprietary information are major challenges impacting market growth.

The report offers a competitive landscape based on an extensive assessment of the leading players' offerings and geographic presence and the key growth strategies adopted by them over the past few years (2021-2024). The key players operating in the global IVD assay development market are Thermo Fisher Scientific Inc. (U.S.), Avioq, Inc. (U.S.), Creative Biolabs, Inc (U.S.), Maxim Biomedical, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), PeploBio Ltd (U.K.), ICON plc (Ireland), NeoDx Biotech Labs Pvt. Ltd. (India), Eclevar Medtech (France), Savyon Diagnostics (Israel), Promega Corporation (U.S.), and Future Diagnostics Solutions B.V. (Netherlands).

Among the offerings covered in this report, the IVD stability testing segment is projected to register the highest CAGR of over 8.1% during the forecast period of 2024-2031. This growth is driven by the benefits of stability testing, which helps identify potential breakdowns or alterations in performance over time. Stability testing enables companies to detect and manage risks related to factors that can affect the effectiveness of IVD assays, including light exposure and temperature variations.

Among the technologies covered in this report, in 2024, the immunoassay /immunochemistry segment is expected to account for the largest share of the IVD assay development market. The segment's large market share is attributed to the higher preference for immunodiagnostics compared to other technologies due to its inherent specificity and high throughput, and the emergence of advanced diagnostic immunoassay formats.

Among the applications covered in this report, in 2024, the infectious diseases segment is expected to account for the largest share of the IVD assay development market. The large market share of this segment can be attributed to the increasing prevalence of HIV and the growing availability of rapid diagnostic assays for HIV.

An in-depth analysis of the geographical scenario of the global IVD assay development market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 37.8% of the IVD assay development market. Within this region, the U.S. is expected to account for the largest share of the IVD assay development market in 2024. The country's large market share is attributed to the increasing prevalence of infectious diseases, favorable government investments and funding for disease investigation & prevention, and rising healthcare expenditure.

Scope of the Report:

IVD Assay Development Market-by Offering

• IVD Assay Development Services
• IVD Packaging Development Services
• IVD Assay Stability Testing
• Regulatory Support
• Other Offerings

(Note: Other offerings include technology transfer, technical support services, and custom QA & QC testing)

IVD Assay Development Market-by Technology

• Immunoassay/Immunochemistry
• Molecular Diagnostics
• Clinical Chemistry/Biochemistry
• Hematology
• Microbiology
• Urinalysis

IVD Assay Development Market-by Application

• Infectious Diseases
• Oncology
• Diabetes
• Cardiology
• Other Applications

(Note: Other applications include nephrology, coagulation tests, and neurological disorders.)

IVD Assay Development Market-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Process
• 2.2. Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
• 2.3. Market Sizing and Forecast
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Factors Affecting Market Growth
  • 4.2.1. Drivers
    • 4.2.1.1. Rising Prevalence of Chronic Diseases & the Increasing Geriatric Population
    • 4.2.1.2. High Burden of Infectious Diseases
    • 4.2.1.3. Growing Focus on the Development of POC IVD Assays
    • 4.2.1.4. Rising Healthcare Expenditures
  • 4.2.2. Restraints
    • 4.2.2.1. Evolving Regulatory Landscape
  • 4.2.3. Opportunities
    • 4.2.3.1. Emerging Economies
    • 4.2.3.2. Use of Advanced Technologies in IVD Assay Development
  • 4.2.4. Challenges
    • 4.2.4.1. Maintaining Product Quality & Protecting Proprietary Information
  • 4.2.5. Macro Indicators
• 4.3. Adjacent Market Analysis
• 4.4. IVD Assay Development Market: Regulatory Landscape
  • 4.4.1. North America
    • 4.4.1.1. U.S.
    • 4.4.1.2. Canada
  • 4.4.2. Europe
  • 4.4.3. Asia-Pacific
    • 4.4.3.1. Japan
    • 4.4.3.2. China
    • 4.4.3.3. India
  • 4.4.4. Latin America
  • 4.4.5. Middle East & Africa
• 4.5. Porter's Five Forces Analysis
  • 4.5.1. Bargaining Power of Suppliers
  • 4.5.2. Bargaining Power of Buyers
  • 4.5.3. Threat of Substitutes
  • 4.5.4. Threat of New Entrants
  • 4.5.5. Degree of Competition

5. IVD Assay Development Market Assessment-by Offering

• 5.1. Overview
• 5.2. IVD Assay Development Services
• 5.3. IVD Assay Stability Testing
• 5.4. IVD Packaging Development Services
• 5.5. Regulatory Support
• 5.6. Other offerings

6. IVD Assay Development Market-by Technology

• 6.1. Overview
• 6.2. Immunoassay/Immunochemistry
• 6.3. Molecular Diagnostics
• 6.4. Clinical Chemistry/Biochemistry
• 6.5. Hematology
• 6.6. Microbiology
• 6.7. Urinalysis

7. IVD Assay Development Market Assessment-by Application

• 7.1. Overview
• 7.2. Infectious Diseases
• 7.3. Oncology
• 7.4. Diabetes
• 7.5. Cardiology
• 7.6. Other Applications

8. IVD Assay Development Market Assessment-by Geography

• 8.1. Overview
• 8.2. North America
  • 8.2.1. U.S.
  • 8.2.2. Canada
• 8.3. Europe
  • 8.3.1. Germany
  • 8.3.2. U.K.
  • 8.3.3. France
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Rest of Europe
• 8.4. Asia-Pacific
  • 8.4.1. China
  • 8.4.2. Japan
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. South Korea
  • 8.4.6. Rest of Asia-Pacific
• 8.5. Latin America
  • 8.5.1. Brazil
  • 8.5.2. Mexico
  • 8.5.3. Rest of Latin America
• 8.6. Middle East & Africa

9. Competition Analysis

• 9.1. Overview
• 9.2. Competitive Benchmarking
• 9.3. Competitive Dashboard
  • 9.3.1. Industry Leaders
  • 9.3.2. Market Differentiators
  • 9.3.3. Vanguards
  • 9.3.4. Emerging Companies
• 9.4. Market Ranking, by Key Players (2023)

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, And SWOT Analysis*)

• 10.1. Creative Biolabs, Inc.
• 10.2. Avioq, Inc.
• 10.4. Thermo Fisher Scientific Inc.
• 10.5. Neodx Biotech Labs Pvt. Ltd.
• 10.6. Merck KGaA
• 10.7. PeploBio Ltd
• 10.8. Icon Plc
• 10.9. Savyon Diagnostics
• 10.10. Maxim Biomedical, Inc.
• 10.11. Eclevar Medtech
• 10.12. Promega Corporation
• 10.13. Future Diagnostics Solutions B.V.

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

11. Appendix

• 11.1. Available Customization
• 11.2. Related Reports

LIST OF TABLES

• Table 1 Healthcare Expenditure per Capita, by Country, 2021/2022 (USD)
• Table 2 Global Human Immunodeficiency Virus (HIV) Statistics, 2023
• Table 3 Percentage of the Population Aged 65 Years or over, by Region, 2022 VS. 2030 VS. 2050
• Table 4 Global IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 5 Global IVD Assay Development Services Market, by Country/Region, 2022-2031 (USD Million)
• Table 6 Global IVD Assay Stability Testing Market, by Country/Region, 2022-2031 (USD Million)
• Table 7 Global IVD Packaging Development Services Market, by Country/Region, 2022-2031 (USD Million)
• Table 8 Global IVD Assay Development Regulatory Support Market, by Country/Region, 2022-2031 (USD Million)
• Table 9 Global Other IVD Assay Development Offerings Market, by Country/Region, 2022-2031 (USD Million)
• Table 10 Global IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 11 Global IVD Assay Development Market for Immunoassay/ Immunochemistry, by Country/Region, 2022-2031 (USD Million)
• Table 12 Global IVD Assay Development Market for Molecular Diagnostics, by Country/Region, 2022-2031 (USD Million)
• Table 13 Global IVD Assay Development Market for Clinical Chemistry/Biochemistry, by Country/Region, 2022-2031 (USD Million)
• Table 14 Global IVD Assay Development Market for Hematology, by Country/Region, 2022-2031 (USD Million)
• Table 15 Global IVD Assay Development Market for Microbiology, by Country/Region, 2022-2031 (USD Million)
• Table 16 Global IVD Assay Development Market for Urinalysis, by Country/Region, 2022-2031 (USD Million)
• Table 17 Global IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 18 Global IVD Assay Development Market for Infectious Diseases, by Country/Region, 2022-2031 (USD Million)
• Table 19 Global IVD Assay Development Market for Oncology, by Country/Region, 2022-2031 (USD Million)
• Table 20 Number of People with Diabetes Aged 20-79 Years, BY Region, 2021 VS. 2030 VS. 2045 (In Million)
• Table 21 Global IVD Assay Development Market for Diabetes, by Country/Region, 2022-2031 (USD Million)
• Table 22 Global IVD Assay Development Market for Cardiology, by Country/Region, 2022-2031 (USD Million)
• Table 23 Global IVD Assay Development Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
• Table 24 Global IVD Assay Development Market, by Country/Region, 2022-2031 (USD Million)
• Table 25 North America: IVD Assay Development Market, by Country, 2022-2031 (USD Million)
• Table 26 North America: IVD Assay Development Market, BY offering, 2022-2031 (USD Million)
• Table 27 North America: IVD Assay Development Market, BY Technology, 2022-2031 (USD Million)
• Table 28 North America: IVD Assay Development Market, BY Application, 2022-2031 (USD Million)
• Table 29 U.S.: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 30 U.S.: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 31 U.S.: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 32 Canada: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 33 Canada: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 34 Canada: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 35 Europe: IVD Assay Development Market, by Country/Region, 2022-2031 (USD Million)
• Table 36 Europe: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 37 Europe: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 38 Europe: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 39 Germany: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 40 Germany: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 41 Germany: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 42 Number of Incidents of Influenza and Other Respiratory Diseases in England, by Institution and Virus Type, Winter 2022 To 2023
• Table 43 U.K.: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 44 U.K.: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 45 U.K.: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 46 France: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 47 France: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 48 France: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 49 Italy: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 50 Italy: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 51 Italy: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 52 Spain: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 53 Spain: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 54 Spain: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 55 Roe: Estimated Number of New Cancer Cases, by Country (2022 Vs. 2030)
• Table 56 Rest of Europe: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 57 Rest of Europe: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 58 Rest of Europe: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 59 Asia-Pacific: IVD Assay Development Market, by Country/Region, 2022-2031 (USD Million)
• Table 60 Asia-Pacific: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 61 Asia-Pacific: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 62 Asia-Pacific: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 63 China: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 64 China: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 65 China: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 66 Japan: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 67 Japan: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 68 Japan: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 69 India: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 70 India: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 71 India: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 72 Australia: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 73 Australia: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 74 Australia: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 75 South Korea: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 76 South Korea: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 77 South Korea: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 78 Rest of Asia-Pacific: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 79 Rest of Asia-Pacific: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 80 Rest of Asia-Pacific: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 81 Latin America: IVD Assay Development Market, by Country/Region, 2022-2031 (USD Million)
• Table 82 Latin America: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 83 Latin America: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 84 Latin America: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 85 Brazil: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 86 Brazil: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 87 Brazil: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 88 Mexico: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 89 Mexico: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 90 Mexico: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 91 Rest of Latin America: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 92 Rest of Latin America: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 93 Rest of Latin America: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 94 Middle East & Africa: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 95 Middle East & Africa: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 96 Middle East & Africa: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 97 Global IVD Assay Development Market Rankings, by Key Players, 2023

LIST OF FIGURES

• Figure 1 Research Process
• Figure 2 Secondary Sources Referenced for This Study
• Figure 3 Primary Research Techniques
• Figure 4 Key Executives Interviewed
• Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
• Figure 6 Market Sizing and Growth Forecast Approach
• Figure 7 Global IVD Assay Development Market, by offering, 2024 Vs.2031 (USD Million)
• Figure 8 Global IVD Assay Development Market, by Technology, 2024 Vs. 2031 (USD Million)
• Figure 9 Global IVD Assay Development Market, by Application, 2024 Vs. 2031 (USD MILLION)
• Figure 10 Global IVD Assay Development Market, by Geography, 2024 VS 2031 (USD Million)
• Figure 11 Impact Analysis of Market Dynamics
• Figure 12 GLOBAL Biopharmaceutical R&D Expenditure, 2016-2026 (USD Billion)
• Figure 13 Estimated Number of New Cancer Cases, by Region, 2022 VS. 2030
• Figure 14 Number of People with Diabetes Aged 20-79 Years, by Region, 2021 VS. 2030 VS. 2045 (in Million)
• Figure 15 IVD Market Share, BY Technology, 2024
• Figure 16 IVD Reagents Market, by Type, 2024 Vs. 2031 (USD Million)
• Figure 17 IVD Contract Manufacturing Services Market, by Type, 2024 Vs. 2031 (USD Million)
• Figure 18 Porter's Five Forces Analysis
• Figure 19 Global IVD Assay Development Market, by offering, 2024 VS. 2031 (USD Million)
• Figure 20 IVD Assay Development Phases
• Figure 21 Global IVD Assay Development Market, by Technology, 2024 VS. 2031 (USD Million)
• Figure 22 Global IVD Assay Development Market, by Application, 2024 VS. 2031 (USD Million)
• Figure 23 Estimated Number of New Cancer Cases, by Region, 2022-2030
• Figure 24 Global IVD Assay Development Market, by Country/Region, 2024 Vs. 2031 (USD Million)
• Figure 25 North America: IVD Assay Development Market Snapshot
• Figure 26 Europe: IVD Assay Development Market Snapshot
• Figure 27 France: Percentage of the Population Aged 65 Years and Above (2016-2020)
• Figure 28 Number of HIV Tests Performed in Catalonia (Spain), 2014-2021
• Figure 29 Asia-Pacific: IVD Assay Development Market Snapshot
• Figure 30 China: Independent Medical Laboratories Market Size (USD Million)
• Figure 31 Japan: Percentage of Aging Population (65 Years and Above), 2016-2050
• Figure 32 Latin America: IVD Assay Development Market Snapshot
• Figure 33 IVD Assay Development Market: Competitive Benchmarking (Based on Offering)
• Figure 34 IVD Assay Development Market: Competitive Benchmarking (Based on Geography)
• Figure 35 Competitive Dashboard: IVD Assay Development Market
• Figure 36 Bio-Techne Corporation: Financial Snapshot (2023)
• Figure 37 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
• Figure 38 Merck KGaA: Financial Snapshot (2023)
• Figure 39 ICON Plc: Financial Snapshot (2023)